Takayuki Yoshino

3 ta ish

National Cancer Center Hospital East

1. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

   Axel Grothey, Eric Van Cutsem, Alberto Sobrero +17

   Maqola20123 iqtibos

   ABIABI:AkademIndex/2026.other.241897

2. Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer

   Thierry André, Kai‐Keen Shiu, Tae Won Kim +18

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.513933

3. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

   Javier Pascual, Gerhardt Attard, François‐Clément Bidard +17

   MaqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.079157